Research Labs

Share
and/or
36 Faculty Members found
Cell Biology Program
Pictured: The Niethammer Lab
Philipp Niethammer, PhD
Cell biologist Philipp Niethammer investigates tissue damage responses with advanced imaging approaches in zebrafish.
Immunology Program
Richard O'Reilly Lab Group
Richard J. O'Reilly, MD
Physician-scientist Richard O'Reilly investigates the genetic disparities and cellular interactions between donor and host that affect allogeneic hematopoietic cell transplantation.
Computational & Systems Biology Program
The Dana Pe'er Lab
Dana Pe'er, PhD
Computational biologist Dana Pe’er combines single-cell and spatial profiling technologies with machine learning approaches to address fundamental questions in gene regulation, cellular plasticity and cell-cell communication in the contexts of cancer, immunity and development.
Memorial Hospital Research Laboratories
Jonathan Peled, MD, PhD
The Peled lab focuses on cancer immunotherapy.
Immunology Program
Justin Perry, PhD
Immunologist Justin Perry investigates homeostatic apoptotic cell clearance and how this process is exploited during cancer development and progression.
Memorial Hospital Research Laboratories
The Vladimir Ponomarev Lab
Vladimir Ponomarev, MD, PhD
Physician-scientist Vladimir Ponomarev focuses on developing reporter genetic systems for specific applications such as sequential in vivo imaging studies in cancer biology, cancer immunotherapy, and radiation sciences.
Immunology Program
The Alexander Rudensky Lab
Alexander Rudensky, PhD
Immunology Program Chair Alexander Rudensky focuses on immunological tolerance and the differentiation and function of T cells.
Immunology Program
Michel Sadelain Lab Group
Michel Sadelain, MD, PhD
Immunologist Michel Sadelain studies the mechanisms governing transgene expression, stem cell engineering, and genetic strategies to enhance immunity against cancer.
Immunology Program
Andrea Schietinger lab
Andrea Schietinger, PhD
Cancer Immunologist Andrea Schietinger investigates immune responses to cancer, molecular mechanisms underlying tumor-induced T cell dysfunction, and new approaches for cancer immunotherapy.
Epidemiology & Biostatistics
Ronglai Shen, PhD
My research has focused on the development of novel statistical and bioinformatic methodologies that facilitate the study of translational research questions in cancer genomics and immuno-oncology.